Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lai Wang currently holds 229,775 shares of BeiGene, Ltd. (BGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lai Wang has been a net seller of BGNE stock. They have purchased $0 and sold $6.2M worth of shares.
Lai Wang's most recent insider trade was on Jun 23, 2026, when they sold 1,068 shares at $276.74 per share.
Lai Wang serves as Executive at BeiGene, Ltd. (BGNE). They have executed 43 insider transactions totaling $6.2M over their tenure at the company.
Lai Wang holds the position of Executive at BeiGene, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Lai Wang has shown a selling trading pattern, with $0 in total purchases and $6.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lai Wang was on May 17, 2022, when they sold $3.5M worth of BGNE shares. This transaction involved 999,999 shares at $3.49 per share.
Lai Wang currently owns 229,775 shares of BeiGene, Ltd. (BGNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lai Wang's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lai Wang has 43 Form 4 filings on record as an insider at BeiGene, Ltd..
Set alerts for Lai Wang and 40,000+ other insiders.